期刊文献+

对1例乳腺癌术后并发肺内感染患者的药学服务

Pharmaceutical Services on A Postoperative Patient of Breast Cancer Complicated by Pneumonic Infection
下载PDF
导出
摘要 临床药师对1例乳癌术后并发肺内感染入院治疗患者的病情进行分析,考虑到化疗药物的骨髓抑制作用,导致患者白细胞减少,免疫力下降,诱发肺内感染,临床药师进行药学查房,提出用药建议,对抗菌药用药方案及不合理用药进行调整,加强不良反应监测,患者治愈出院。 The illness conditions of a female postoperative patient of breast cancer complicated by pneumonic infection were analyzed after giving treatment during her hospitalization. Considering bone marrow suppression caused by chemotherapy may lead the patient to leucocytopenia, the immune suppression and lung infection, clinical pharmacists conducted the ward inspections and made suggestions to adjust the use of antibacterial drugs, improve the irrational use of drugs in medication and pay more attention to monitoring the adverse drug reactions. As the result, the patient was discharged from hospital after recovery.
出处 《中国执业药师》 CAS 2011年第12期6-9,共4页 China Licensed Pharmacist
关键词 临床药师 药学服务 乳腺癌 并发症 术后 肺内感染 Clinical Pharmacist Pharmacy Service Breast Cancer Complications,Postoperative Pneumonic Infection
  • 相关文献

参考文献7

  • 1洪小南,王佳蕾,孙曾一.肿瘤学概论[M]//陈灏珠,林果为.实用内科学(上册).13版.北京:人民卫生出版社,2009:166-191.
  • 2卫生部,国家中医药管理局,总后卫生部.抗菌药物临床应用指导原则[S].卫医发(2004)285号.2004-08-19.
  • 3陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:64.
  • 4卫生部合理用药专家委员会.中国医师药师临床用药指南[M].重庆:重庆出版集团重庆出版社,2009:700-701.
  • 5汪复,吴菊芳.免疫缺陷者感染[M]//陈灏珠,林果为.实用内科学(上册)13版.北京:人民卫生出版社,2009:326-332.
  • 6肖永红.新型抗菌药物研究进展[J].中国执业药师,2011,8(6):9-15. 被引量:4
  • 7国家药典委员会.中华人民共和国药典临床用药须知2010年版[M].北京:中国医药科技出版社,2011:812-814.

二级参考文献34

  • 1Wunderink RG,Rello J,Cammarata SK,et al.Linezolid vs vancomycin:analysis of two double-blind studies of patients with methiciilin-resistant Staphylococcus aureus nosocomial pneumonia[J].Chest,2003,124(5):1789-1797.
  • 2Sánchez García M,De la Torre MA,Morales G,et al.Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit[J].JAMA,2010,303(22):2260-2264.
  • 3Bush K,Macielag MJ.New β-lactam antibiotics and β-lactama se inhibitors[J].Expert Opin Ther Pat,2010,20(10):1277-1293.
  • 4Petrikkos GL.Lipid formulation of amphotericin B as first-line treatment of zygomycosis[J].Clin Microbiol Infect,2009,15(S5):87-92.
  • 5Moen MD,Lyseng-Willianson KA,Sott LJ.Liposomal amphotericin B:a review of its use as empirical therapy in febrile neutopenia and in the treatment of invasive fungal infections[J].Drugs,2009,69(3):361-392.
  • 6Thompsom GR,Lewis JS.Pharmacology and clinical use of voric onazole[J].Expert Opin Drug Metab Toxicol,2010,6(1):83-94.
  • 7Thompson GR,Cadena J,Patttersun TF.Overview of antifungal agents[J].Clin Chest Med,2009,30(2):203-215.
  • 8Fera MT,La Cslnera E,De Sane A.New triazole and echinocandins:mode of action,invitro activity and mechanisms of resistance[J].Expert Rev Anti Infect Ther,2009,7(8):981-998.
  • 9Boucher HW,Talbot GH,Bradley JS,et al.Bad bugs,no drugs:no ESKAPE! An update from the lnfectious Diseases Society of America[J].Clin Infect Dis,2009,48(1):1-12.
  • 10Fischbach MA,Walsh CT.Antibiotics for emerging pathogens[J].Science,2009,325(5944):1089-1093.

共引文献396

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部